hTERT rs2736098 genetic variants and susceptibility of hepatocellular carcinoma in the Chinese population: a case-control study

Farazi, 2006, Hepatocellular carcinoma pathogenesis: from genes to environment, Nat Rev Cancer, 6, 674, 10.1038/nrc1934 Molmenti, 2001, Hepatocellular cancer in liver transplantation, J Hepatobiliary Pancreat Surg, 8, 427, 10.1007/s005340100005 El-Serag, 2007, Hepatocellular carcinoma: epidemiology and molecular carcinogenesis, Gastroenterology, 132, 2557, 10.1053/j.gastro.2007.04.061 Wang, 2005, Preparation and analysis of cSNP chip on hepatocellular carcinoma-related genes, Hepatobiliary Pancreat Dis Int, 4, 398 Fabris, 2009, MTHFR C677T polymorphism and risk of HCC in patients with liver cirrhosis: role of male gender and alcohol consumption, Alcohol Clin Exp Res, 33, 102, 10.1111/j.1530-0277.2008.00816.x Artandi, 2010, Telomeres and telomerase in cancer, Carcinogenesis, 31, 9, 10.1093/carcin/bgp268 Savage, 2007, Genetic variation in five genes important in telomere biology and risk for breast cancer, Br J Cancer, 97, 832, 10.1038/sj.bjc.6603934 Ozturk, 2009, Senescence and immortality in hepatocellular carcinoma, Cancer Lett, 286, 103, 10.1016/j.canlet.2008.10.048 Dharel, 2006, MDM2 promoter SNP309 is associated with the risk of hepatocellular carcinoma in patients with chronic hepatitis C, Clin Cancer Res, 12, 4867, 10.1158/1078-0432.CCR-06-0111 Tanabe, 2008, Epidermal growth factor gene functional polymorphism and the risk of hepatocellular carcinoma in patients with cirrhosis, JAMA, 299, 53, 10.1001/jama.2007.65 Wang, 2006, Interleukin-10 promoter polymorphisms in patients with hepatitis B virus infection or hepatocellular carcinoma in Chinese Han ethnic population, Hepatobiliary Pancreat Dis Int, 5, 60 Zhai, 2006, Estrogen receptor alpha polymorphisms associated with susceptibility to hepatocellular carcinoma in hepatitis B virus carriers, Gastroenterology, 130, 2001, 10.1053/j.gastro.2006.02.030 Rafnar, 2009, Sequence variants at the TERT-CLPTM1L locus associate with many cancer types, Nat Genet, 41, 221, 10.1038/ng.296 Choi, 2009, Polymorphisms in telomere maintenance genes and risk of lung cancer, Cancer Epidemiol Biomarkers Prev, 18, 2773, 10.1158/1055-9965.EPI-09-0323 Bruix, 2005, Management of hepatocellular carcinoma, Hepatology, 42, 1208, 10.1002/hep.20933 2005, Department of Health and Human Services and the Department of Agriculture, Alcoholic Beverages, 44 Eberl, 2005, Patients with a family history of cancer: identification and management, J Am Board Fam Pract, 18, 211, 10.3122/jabfm.18.3.211 Akkiz, 2009, G-308A TNF-alpha polymorphism is associated with an increased risk of hepatocellular carcinoma in the Turkish population: case-control study, Cancer Epidemiol, 33, 261, 10.1016/j.canep.2009.06.001 Ezzikouri, 2009, MDM2 SNP309T>G polymorphism and risk of hepatocellular carcinoma: a case-control analysis in a Moroccan population, Cancer Detect Prev, 32, 380, 10.1016/j.cdp.2009.01.003 Qi, 2009, No association of EGF 5′UTR variant A61G and hepatocellular carcinoma in Chinese patients with chronic hepatitis B virus infection, Pathology, 41, 555, 10.1080/00313020903071603 Nakayama, 1998, Telomerase activation by hTRT in human normal fibroblasts and hepatocellular carcinomas, Nat Genet, 18, 65, 10.1038/ng0198-65 Kyo, 2002, Complex regulatory mechanisms of telomerase activity in normal and cancer cells: how can we apply them for cancer therapy?, Oncogene, 21, 688, 10.1038/sj.onc.1205163 Grochola, 2008, Prognostic relevance of hTERT mRNA expression in ductal adenocarcinoma of the pancreas, Neoplasia, 10, 973, 10.1593/neo.08578 Cairney, 2008, Telomerase redefined: integrated regulation of hTR and hTERT for telomere maintenance and telomerase activity, Biochimie, 90, 13, 10.1016/j.biochi.2007.07.025 Calado, 2009, Telomere diseases, N Engl J Med, 361, 2353, 10.1056/NEJMra0903373 Kimchi-Sarfaty, 2007, A “silent” polymorphism in the MDR1 gene changes substrate specificity, Science, 315, 525, 10.1126/science.1135308 Duan, 2003, Synonymous mutations in the human dopamine receptor D2 (DRD2) affect mRNA stability and synthesis of the receptor, Hum Mol Genet, 12, 205, 10.1093/hmg/ddg055 Komar, 2007, Genetics. SNPs, silent but not invisible, Science, 315, 466, 10.1126/science.1138239 Varadi, 2009, A functional promoter polymorphism in the TERT gene does not affect inherited susceptibility to breast cancer, Cancer Genet Cytogenet, 190, 71, 10.1016/j.cancergencyto.2008.12.006 Wang, 2006, Cyclin D1 splice variant and risk for non-Hodgkin lymphoma, Hum Genet, 120, 297, 10.1007/s00439-006-0212-3 Bréchot, 2004, Pathogenesis of hepatitis B virus-related hepatocellular carcinoma: old and new paradigms, Gastroenterology, 127, S56, 10.1053/j.gastro.2004.09.016 Koike, 2005, Molecular basis of hepatitis C virus-associated hepatocarcinogenesis: lessons from animal model studies, Clin Gastroenterol Hepatol, 3, S132, 10.1016/S1542-3565(05)00700-7 Henson, 2002, Alternative lengthening of telomeres in mammalian cells, Oncogene, 21, 598, 10.1038/sj.onc.1205058 Saini, 2009, Telomerase activity, telomere length and human telomerase reverse transcriptase expression in hepatocellular carcinoma is independent of hepatitis virus status, Liver Int, 29, 1162, 10.1111/j.1478-3231.2009.02082.x